{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:07:02Z","timestamp":1760188022275},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1053\/berh.1999.0038","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"479-485","source":"Crossref","is-referenced-by-count":10,"title":["Drug therapy"],"prefix":"10.1053","volume":"13","author":[{"given":"Dan","family":"Buskila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/berh.1999.0038_RF1","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/art.1780400904","article-title":"A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia","volume":"40","author":"Wolfe","year":"1997","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.1999.0038_RF2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0889-857X(21)01005-X","article-title":"Management of fibromyalgia syndrome","volume":"15","author":"Goldenberg","year":"1989","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"10.1053\/berh.1999.0038_RF3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0889-857X(05)70275-1","article-title":"A cost-effective approach to the diagnosis and treatment of fibromyalgia","volume":"22","author":"McCain","year":"1996","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"10.1053\/berh.1999.0038_RF4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00000441-199806000-00008","article-title":"Advances in the treatment of fibromyalgia: current status and future directions","volume":"315","author":"Alarcon","year":"1998","journal-title":"American Journal of the Medical Sciences"},{"key":"10.1053\/berh.1999.0038_RF5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/art.1780290510","article-title":"Evaluation of amitriptyline in primary fibrositis: a double-blind, placebo-controlled study","volume":"29","author":"Carette","year":"1986","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.1999.0038_RF6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.1780291110","article-title":"A randomized controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia","volume":"29","author":"Goldenberg","year":"1986","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.1999.0038_RF7","first-page":"98","article-title":"Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline","volume":"16","author":"Scudds","year":"1989","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF8","first-page":"447","article-title":"Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials","volume":"18","author":"Jaeschke","year":"1991","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/art.1780370106","article-title":"Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, double-blind clinical trial","volume":"37","author":"Carette","year":"1994","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.1999.0038_RF10","first-page":"99","article-title":"Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome","volume":"12","author":"Fossaluzza","year":"1992","journal-title":"International Journal of Clinical Pharmacology Research"},{"key":"10.1053\/berh.1999.0038_RF11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/03009749409103725","article-title":"A double-blind placebo controlled trial of fluoxetine in fibromyalgia","volume":"23","author":"Wolfe","year":"1994","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF12","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/art.1780391111","article-title":"A randomized double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia","volume":"39","author":"Goldenberg","year":"1996","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.1999.0038_RF13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0304-3959(94)00218-4","article-title":"A randomized controlled trial of citalopram in the treatment of fibromyalgia","volume":"61","author":"Norregaard","year":"1995","journal-title":"Pain"},{"key":"10.1053\/berh.1999.0038_RF14","first-page":"S259","article-title":"Sertraline hydrochloride (Zoloft) alters pain threshold, sensory discrimination ability, and functional brain activity in patients with fibromyalgia (FM): a randomized controlled trial (RCT)","volume":"41","author":"Alberts","year":"1998","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.1999.0038_RF15","first-page":"1418","article-title":"Pathogenic aspects of responsiveness to ondansetron (5-hydroxytryptamine type 3 receptor antagonist) in patients with primary fibromyalgia syndrome\u2014a preliminary study","volume":"23","author":"Hrycaj","year":"1996","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF16","first-page":"17","article-title":"The 5-HT3 blockers in the treatment of the primary fibromyalgia syndrome: a 10-day open study with tropisetron at a low dose","volume":"28","author":"Samborski","year":"1996","journal-title":"Materia Medica Polona"},{"key":"10.1053\/berh.1999.0038_RF17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF01452251","article-title":"A randomized double-blind 16-week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of autoantibodies to serotonin gangliosides and phospholipids","volume":"17","author":"Olin","year":"1998","journal-title":"Clinical Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0033-3182(98)71375-1","article-title":"An open clinical trial of venlafaxine treatment of fibromyalgia","volume":"39","author":"Dwight","year":"1998","journal-title":"Psychosomatics"},{"key":"10.1053\/berh.1999.0038_RF19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/art.1780340507","article-title":"Treatment of primary fibrositis\/fibromyalgia syndrome with ibuprofen and alprazolam: a double-blind, placebo-controlled study","volume":"34","author":"Russell","year":"1991","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.1999.0038_RF20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3959(95)00199-9","article-title":"Comparison of tenoxicam and bromazepam in the treatment of fibromyalgia: a randomized, double-blind, placebo controlled trial","volume":"65","author":"Carrera","year":"1996","journal-title":"Pain"},{"key":"10.1053\/berh.1999.0038_RF21","first-page":"S259","article-title":"Effect of lorazepam on pain score for refractory fibromyalgia","volume":"41","author":"Holman","year":"1998","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.1999.0038_RF22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3109\/03009749109096802","article-title":"Zopiclone in the treatment of sleep abnormalities in fibromyalgia","volume":"20","author":"Drewes","year":"1991","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF23","first-page":"529","article-title":"The effect of zolpidem on patients with fibromyalgia: a dose ranging double-blind, placebo controlled, modified crossover study","volume":"23","author":"Moldofsky","year":"1996","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF24","first-page":"980","article-title":"A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis","volume":"12","author":"Clark","year":"1985","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF25","first-page":"S117","article-title":"Efficacy of ultralam (tramadol HCL) treatment of fibromyalgia syndrome: preliminary analysis of a multi-center randomized, placebo-controlled study","volume":"40","author":"Russell","year":"1997","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/berh.1999.0038_RF26","first-page":"146","article-title":"A blinded, placebo-controlled evaluation of tramadol in the management of fibromyalgia pain","volume":"6","author":"Bennett","year":"1998","journal-title":"Journal of Musculoskeletal Pain"},{"key":"10.1053\/berh.1999.0038_RF27","first-page":"115","article-title":"Intravenous lignocaine in the management of primary fibromyalgia syndrome","volume":"15","author":"Bennett","year":"1995","journal-title":"International Journal of Clinical Pharmacological Research"},{"key":"10.1053\/berh.1999.0038_RF28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/03009749509095181","article-title":"Pain analysis in patients with fibromyalgia: effects of intravenous morphine, lidocaine, and ketamine","volume":"24","author":"Sorensen","year":"1995","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF29","first-page":"1615","article-title":"Fibromyalgia: are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs","volume":"24","author":"Sorensen","year":"1997","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3109\/03009749109096803","article-title":"Oral S -adenosylmethionine in primary fibromyalgia: Double-blind clinical evaluation","volume":"20","author":"Jacobsen","year":"1991","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0002-9343(87)90862-X","article-title":"Evaluation of S -adenosylmethionine in primary fibromyalgia: A double-blind crossover study","volume":"83","author":"Tavoni","year":"1987","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.1999.0038_RF32","first-page":"106","article-title":"Evaluation of S -adenosylmethionine in secondary fibromyalgia: a double blind study","volume":"16","author":"Tavoni","year":"1998","journal-title":"Clinical Experimental Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/030097498440976","article-title":"A placebo controlled crossover trial of subcutaneous salmon calcitonin in the treatment of patients with fibromyalgia","volume":"27","author":"Bessette","year":"1998","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1053\/berh.1999.0038_RF34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000119138","article-title":"Effect of an antidiencephalon immune serum on pain and sleep in primary fibromyalgia","volume":"30","author":"Kempenaers","year":"1994","journal-title":"Neuropsychobiology"},{"key":"10.1053\/berh.1999.0038_RF35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9343(97)00351-3","article-title":"A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia","volume":"104","author":"Bennett","year":"1998","journal-title":"American Journal of Medicine"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694299900384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694299900384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T04:58:12Z","timestamp":1682139492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694299900384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["S1521694299900384"],"URL":"https:\/\/doi.org\/10.1053\/berh.1999.0038","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}